PGD-peptide and P-selectin, when combined with liposomal NP, have the ability to bind to different tumour areas by overexpressing their respective receptors on breast cancer cells (139)
Currently, there are other dual GIPR/GLP-1R agonists available, such as GLP-1R/GR (glucagon receptor), GLP-1R/AR (amylin receptor), and GLP-1R/NPYR (peptide YY binds to neuropeptide Y receptors) [36, 115] and even triple agonists that can activate GIPR to treat obesity and T2DM
Unlike traditional weight loss clinics that require in-person visits, Brello's model brings board-certified clinicians, prescription management, and expert health coaches directly to your smartphone or computer
Kondo M, Koyama Y, Nakamura Y, Shimada S